Cipher Pharmaceuticals Inc.
CPHRF
$10.35
-$0.12-1.11%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.90% | 134.87% | 298.06% | 1,843.82% | 96.76% |
| Total Depreciation and Amortization | -1.88% | -1.26% | 19.06% | -6.75% | 518.84% |
| Total Amortization of Deferred Charges | 35.14% | 18.42% | 15.38% | 77.27% | -- |
| Total Other Non-Cash Items | 201.87% | 36.64% | -112.88% | -1,280.00% | -830.00% |
| Change in Net Operating Assets | -294.31% | -1,479.13% | -72.09% | 1,575.40% | -132.32% |
| Cash from Operations | -49.34% | 7.16% | -1.77% | 437.36% | -3.29% |
| Capital Expenditure | -- | 50.00% | -257.14% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -24,500.00% | -1,585.71% | 100.06% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.50% | -6,581.58% | -11,452.86% | -11,282.08% | -51,893.10% |
| Issuance of Common Stock | 1,620.00% | 12.90% | 760.00% | 350.00% | -58.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.56% | -11,106.67% | -9,146.15% | -134.43% | -344,120.00% |
| Foreign Exchange rate Adjustments | -135.85% | -600.00% | 116.27% | -334.62% | 357.28% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 125.34% | -126.01% | -111.20% | 92.42% | -277.59% |